BenjaminZevLederMD
Endocrinology • Boston, MADiabetes, Lipid Metabolism
Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Dr. Leder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Parkman Street Wac 730s
Endocrine Associates
Boston, MA 02114Phone+1 617-726-8720Fax+1 617-724-2718
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2000- Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1997
Harvard Medical SchoolClass of 1994
Certifications & Licensure
MA State Medical License 1998 - 2026- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Elected Member The American Society for Clinical Investigation, 2011
Clinical Trials
- Anastrozole Administration in Elderly Hypogonadal Men Start of enrollment: 2004 Oct 01
- Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis Start of enrollment: 2009 Jun 01
- Testosterone and Alendronate in Hypogonadal Men Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 308 citationsDenosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trialBenjamin Z. Leder, Joy N. Tsai, Alexander V. Uihlein, Paul M. Wallace, Hang Lee
Lancet. 2015-09-19 - 11 citationsSequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis.Sabashini K Ramchand, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism. 2024-01-18 - 110 citationsGonadal steroid–dependent effects on bone turnover and bone mineral density in menJoel S. Finkelstein, Hang Lee, Benjamin Z. Leder, Sherri-Ann M. Burnett-Bowie, David W. Goldstein
The Journal of Clinical Investigation. 2016-03-01
Press Mentions
Don’t Let Knowledge Gaps Hold Back Fracture Prevention Efforts, Experts SayOctober 15th, 2019
ASBMR: High-Dose Forteo plus Prolia Increased BMDOctober 2nd, 2018
Denosumab Increases Bone Density, Cuts Fracture Risk in Prostate Cancer SurvivorsAugust 11th, 2009- Join now to see all
Grant Support
- Aromatase Inhibition In Elderly Hypogonadal MenNational Institute On Aging2005–2009
- Clinical Trial: Anastrozole Administration In Elderly Hypogonadal MenNational Center For Research Resources2008
- Anastrozole Administration In Elderly Hypogonadal MenNational Center For Research Resources2005–2007
- Does Increased Education Of Side Effects/Increase Subj'S Reporting Side EffectsNational Center For Research Resources2005–2006
- Effects Of Androgens And Estrogens On Skeletal Sensitivity To PTHNational Center For Research Resources2004–2006
- Differential Effects Of Gonadal Steroids On BoneNational Center For Research Resources2001–2005
- Anastrozole Admin On Gonadal Steroid Levels In Elderly Men W/ Mild HypogonadismNational Center For Research Resources2004
- Differential Effects Of Androgens And Estrogens On BoneNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
